Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00826930
What this trial is testing

Trans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade Glioma

Who this might be right for
High Grade Glioma
Diffusion Pharmaceuticals Inc 1
Testing effectiveness (Phase 2)Study completedNCT01248936
What this trial is testing

RO5185426 in Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 374
Testing effectiveness (Phase 2)Looking for participantsNCT06622434
What this trial is testing

New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study

Who this might be right for
Newly Diagnosed Glioblastoma
Assistance Publique - Hôpitaux de Paris 35
Early research (Phase 1)UnknownNCT04357509
What this trial is testing

The Tolerance,Pharmacokinetic Characteristics,Safety and Efficacy of ScTIL210 in the Treatment of Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 32
Not applicableEnded earlyNCT04763031
What this trial is testing

Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT

Who this might be right for
GlioblastomaGBMRecurrent GBM
Parkridge Medical Center 1
Not applicableStudy completedNCT00928031
What this trial is testing

Long-term Data Collection for Subjects in MDX-010 Studies

Who this might be right for
Metastatic Melanoma
Bristol-Myers Squibb 160
Testing effectiveness (Phase 2)Study completedNCT00150072
What this trial is testing

Efficacy and Safety of Imatinib in Chordoma

Who this might be right for
Chordoma
Novartis Pharmaceuticals 55
Very early researchStudy completedNCT03647657
What this trial is testing

177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer

Who this might be right for
Thyroid Cancer, Medullary
University Hospital, Basel, Switzerland 8
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Looking for participantsNCT06607692
What this trial is testing

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Who this might be right for
Solid Tumor CancerMedulloblastomaHigh Risk Neuroblastoma+19 more
Fundación de investigación HM 25
Testing effectiveness (Phase 2)Looking for participantsNCT07537400
What this trial is testing

Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5

Who this might be right for
High-Risk Neuroblastoma
Shaare Zedek Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT02537600
What this trial is testing

Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis

Who this might be right for
Malignant Melanoma
Center Eugene Marquis 43
Not applicableStudy completedNCT03666507
What this trial is testing

Vegetative Monitoring During Brainstem-associated Surgery

Who this might be right for
Brain Tumor, RecurrentVestibular SchwannomaBrainstem Neoplasm+1 more
University Hospital Tuebingen 103
Very early researchEnded earlyNCT02279992
What this trial is testing

Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases

Who this might be right for
GliomaBrain NeoplasmsBrain Metastasis
Cedars-Sinai Medical Center 7
Not applicableStudy completedNCT03973892
What this trial is testing

Remote Brain Microhaemorrhages May Predict Haematoma in Glioma Patients Treated With Radiation Therapy

Who this might be right for
Glioma
Fondation Ophtalmologique Adolphe de Rothschild 58
Not applicableStudy completedNCT00506311
What this trial is testing

Evaluating the Use of Fibrin Tissue Adhesive in Melanoma Patients

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 53
Testing effectiveness (Phase 2)Ended earlyNCT00617890
What this trial is testing

Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)

Who this might be right for
OsteosarcomaSarcoma, Ewing'sPeripheral Neuroectodermal Tumor
Merck Sharp & Dohme LLC 219
Testing effectiveness (Phase 2)Study completedNCT01636882
What this trial is testing

CAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks (VLA-008 CALM Ext)

Who this might be right for
Melanoma
Viralytics 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07811297
What this trial is testing

Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers

Who this might be right for
Endometrial NeoplasmsOvarian NeoplasmsSoft Tissue Sarcoma (STS)+1 more
Advenchen Pharmaceuticals, LLC. 138
Early research (Phase 1)Study completedNCT00730613
What this trial is testing

Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
City of Hope Medical Center 3
Next Page